 |
|
Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc. 2021;62(9):1218-1226. Published online 2021 Sep 15 DOI: https://doi.org/10.3341/jkos.2021.62.9.1218
|
|
Citations to this article as recorded by
 Initial Factors Associated with Resistance to Intravitreal Aflibercept Injection in Polypoidal Choroidal Vasculopathy
Dayoung Moon, Minsub Lee, Hyewon Chung, Hyungwoo Lee
Journal of the Korean Ophthalmological Society.2024; 65(7): 425. CrossRef Clinical Outcomes of Double-dose Aflibercept Treatment for Refractory Wet Age-related Macular Degeneration
Sung Hyun Jo, Han Jo Kwon, Sung Who Park, Ik Soo Byon
Journal of the Korean Ophthalmological Society.2024; 65(8): 500. CrossRef Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Daeun Shin, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2022; 63(6): 526. CrossRef
|